NDC 69911-490 - AFSTYLA Antihemophilic Factor (Recombinant), Single Chain

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
69911-490
Package NDCs from labels
69911-490-01
Manufacturer
CSL Behring Lengnau AG | CSL Behring GmbH | CSL Behring LLC
Effective date
2023-06-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
LONOCTOCOG ALFA - CSL Behring Lengnau AG | CSL Behring GmbH | CSL Behring LLCCSL Behring Lengnau AG | CSL Behring GmbH | CSL Behring LLC2023-06-23PLASMA DERIVATIVE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69911-490-01AFSTYLA Antihemophilic Factor (Recombinant), Single Chain5 mL in 1 VIAL, SINGLE-USEINJECTION, POWDER, FOR SOLUTION5 mL1500 [iU] in 5mL13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69911-490AFSTYLA ANTIHEMOPHILIC FACTOR (RECOMBINANT), SINGLE CHAIN (ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT) KIT [CSL BEHRING LENGNAU AG]13Unmatched20230630_51f19873-a63f-4229-9477-5da4ecf31cde.zip